PerpEquities

Laporan laba rugi Twist Bioscience Corporation (TWST)

NASDAQ · Healthcare · Biotechnology · Karyawan: 979 · CEO: Emily Marine Leproust

Harga
$152,78 -11,92%
Kapitalisasi pasar
$10,1 M
Nilai perusahaan
$10 M
Laporan terakhir
Q3 '26 diajukan 2026-08-03
Laporan berikutnya
2026-11-12 Estimasi EPS: -$0,38

Twist Bioscience Corporation (TWST) untuk Q3 '26: pendapatan $118 jt (+23,2% yoy), laba operasional -$36,3 jt (-30,6% dari pendapatan), laba bersih -$35,1 jt. Dalam empat kuartal terakhir pendapatan mencapai $432 jt.

Laporan laba rugi

Laporan laba rugiTrenQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Pendapatan$66,9 jt$71,5 jt$75,3 jt$81,5 jt$84,7 jt$88,7 jt$92,8 jt$96,1 jt$99 jt$104 jt$111 jt$118 jt
Beban pokok pendapatan$42,4 jt$42,5 jt$44,4 jt$46,2 jt$46,5 jt$45,9 jt$46,8 jt$44,8 jt$48,2 jt$49,7 jt$53,6 jt$55,9 jt
Laba kotor$24,5 jt$29 jt$30,9 jt$35,3 jt$38,2 jt$42,8 jt$46 jt$51,3 jt$50,8 jt$54 jt$57,1 jt$62,5 jt
Riset & pengembangan$23,7 jt$23,1 jt$24,1 jt$22,5 jt$21,1 jt$21,3 jt$23,9 jt$18 jt$17 jt$17,1 jt$19,7 jt$18 jt
Penjualan & pemasaran$0$0$0$0$0$0$0$0$7 jt$0$0$0
Umum & administrasi$0$0$0$0$0$0$0$0$56,8 jt$0$0$0
Beban operasional lainnya$3,5 jt-$31 rb-$199 rb$44,9 jt$0$0$0$0$0$0$0$0
Beban operasional$74,6 jt$75,9 jt$79,8 jt$124 jt$74,3 jt$77,5 jt$87,6 jt$81,4 jt$80,8 jt$86,9 jt$95,8 jt$98,7 jt
Laba operasional-$50,1 jt-$47 jt-$48,9 jt-$88,9 jt-$36 jt-$34,6 jt-$41,6 jt-$30,1 jt-$29,9 jt-$32,9 jt-$38,7 jt-$36,3 jt
Pendapatan bunga$3,89 jt$4,12 jt$3,94 jt$3,66 jt$3,62 jt$3,24 jt$2,8 jt$2,69 jt$2,63 jt$2,18 jt$1,71 jt$1,5 jt
Beban bunga$1 rb$0$0$0$29 rb$24 rb$143 rb$0$0$0$0$0
Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...)-$3,65 jt-$4,09 jt-$3,74 jt-$3,54 jt-$1,32 jt-$3,17 jt-$2,55 jt-$50,7 jt-$3,05 jt$0$0-$1,54 jt
Total pendapatan non-operasional$3,65 jt$4,09 jt$3,74 jt$3,54 jt$1,48 jt$3,15 jt$2,41 jt$50,7 jt$3,05 jt$2,65 jt-$5,32 jt$1,54 jt
Laba sebelum pajak-$46,5 jt-$42,9 jt-$45,1 jt-$85,4 jt-$34,6 jt-$31,5 jt-$39,2 jt$20,6 jt-$26,9 jt-$30,3 jt-$44 jt-$34,7 jt
Pajak penghasilan-$222 rb$120 rb$345 rb$191 rb-$96 rb$97 rb$175 rb$191 rb$256 rb$253 rb$43 rb-$311 rb
Laba bersih-$46,2 jt-$43 jt-$45,5 jt-$85,6 jt-$34,7 jt-$31,6 jt-$39,3 jt$20,4 jt-$27,1 jt-$30,5 jt-$44 jt-$35,1 jt
EPS (dasar)-$0,81-$0,75-$0,79-$1,47-$0,60-$0,53-$0,66$0,34-$0,45-$0,50-$0,71-$0,56
EPS (dilusian)-$0,81-$0,75-$0,79-$1,47-$0,60-$0,53-$0,66$0,33-$0,45-$0,50-$0,71-$0,56
Saham (dasar, rata-rata tertimbang)57,3 jt57,5 jt57,8 jt58,1 jt58 jt59,2 jt59,6 jt60 jt60,4 jt61,1 jt61,7 jt62,4 jt
Saham (dilusian, rata-rata tertimbang)57,3 jt57,5 jt57,8 jt58,1 jt58 jt59,2 jt59,6 jt61,2 jt60,4 jt61,1 jt61,7 jt62,4 jt
Depresiasi & amortisasi$8,5 jt$8,17 jt$8,3 jt$8,3 jt$6,66 jt$6,38 jt$6,4 jt$6,07 jt$6 jt$6,19 jt$6,41 jt$6,78 jt
EBITDA-$38 jt-$34,7 jt-$36,8 jt-$77,1 jt-$28,1 jt-$25,1 jt-$32,6 jt$26,6 jt-$20,9 jt-$26,7 jt-$32,2 jt-$28 jt

Distandardisasi dari laporan perusahaan; arus keluar dan biaya mempertahankan tanda yang dilaporkan penyedia. Arahkan kursor ke periode untuk melihat tanggal berakhirnya. Jumlah dalam USD.

Pendapatan, laba operasional, dan pertumbuhan

kuartalan

Margin

kuartalan

Biaya sebagai % pendapatan

kuartalan

Laporan lainnya

Sumber

Laporan keuangan, pendapatan segmen, metrik, dan estimasi distandardisasi dari laporan perusahaan. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-Q 2025-12-31, 10-K 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-Q 2024-12-31, 10-K 2024-09-30, 10-Q 2024-06-30

Data per 2026-11-02